Precision Business Insights
Portfolio

 

Research Reports

Oligonucleotide Synthesis Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global Oligonucleotide Synthesis Market

 

 

Oligonucleotide Synthesis Market: By Product (Synthesized oligonucleotides, Reagents, Equipment), By Application (Diagnostics, Research, Therapeutics), By End-Users (Diagnostic Laboratories, Research Institutes, Biotechnology & Pharmaceutical Companies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global oligonucleotide synthesis market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Oligonucleotide Synthesis Market

Oligonucleotide Synthesis Market

 

 

Market Outline: Oligonucleotide Synthesis Market

Oligonucleotide Synthesis is synthesis of short fragments of the nucleic acids which has a defined chemical structure. This process of chemical synthesis enables provide a rapid access to the custom-made oligonucleotides. The building blocks are coupled sequentially which further helps in growing the customized oligonucleotide chain.

Market Dynamics: Oligonucleotide Synthesis Market

The increase in adoption of advanced technologies are expected to increase the growth of oligonucleotide synthesis market. The surge in initial investments in research and development, companies focused on novel technologies are anticipated to fuel the growth of oligonucleotide synthesis market. Furthermore, these R&D activities are adding scope for the advent of new products which is likely to enhance the growth of the oligonucleotide synthesis market, providing opportunities to the manufactures. The increasing government support in developing technologies such as the oligonucleotide synthesis technology and the genomic technologies is enriching the growth of the market. Personalized medicine is playing a vital role, expected to add fuel for the growth of oligonucleotide synthesis market. However, the stringent government regulations in approval of oligonucleotide-based therapeutics are expected to hamper the growth of the market.

Market Scope: Oligonucleotide Synthesis Market

Oligonucleotide synthesis market is segmented based on the product, application, and end-user

Based on the product, the market is segmented into the following:

  • Synthesized oligonucleotides
    • DNA oligonucleotides
    • RNA oligonucleotides
    • Others
  • Reagents
  • Equipment

Based on the application, the market is segmented into the following:

  • Diagnostics
  • Research
  • Therapeutics

Based on the end-user, the market is segmented into the following:

  • Diagnostic Laboratories
  • Research Institutes
  • Biotechnology & Pharmaceutical Companies

Regional Analysis:  Oligonucleotide Synthesis Market

Geographically, global oligonucleotide synthesis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America oligonucleotide synthesis market is dominant and is expected to hold its position over the forecasted period. The soaring advancements in the healthcare sector, increased investments in biotechnology is expected to witness the growth of the market. The increasing R&D activities, sophisticated infrastructure expected to fuel the market. The Asia Pacific oligonucleotide synthesis market is expected to accelerate the growth in the forecasted period owing to emerging economies such as China and India, which enables increase the growth of oligonucleotide synthesis market.

Competition Assessment: Oligonucleotide Synthesis Market

Some of the players in this market include:

  • Thermo Fisher Scientific Inc. (U.S)
  • Integrated DNA Technologies, Inc. (U.S)
  • Sigma-Aldrich Corporation (U.S)
  • GE Healthcare (U.S)
  • Eurofins Genomics (Germany)
  • Nitto Denko Avecia Inc. (Japan)
  • Agilent Technologies Inc. (U.S)

Notable Market Developments

  • In October 2017, Integrated DNA Technologies has acquired oligonucleotide manufacturing business of GeneWorks Pty Ltd. (GeneWorks) in Australia

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Thermo Fisher Scientific Inc. (U.S)
  • Integrated DNA Technologies, Inc. (U.S)
  • Sigma-Aldrich Corporation (U.S)
  • GE Healthcare (U.S)
  • Eurofins Genomics (Germany)
  • Nitto Denko Avecia Inc. (Japan)
  • Agilent Technologies Inc. (U.S)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Contact SalesTOLL FREE: +1-866-598-1553